Related Experiment Video
Updated: Sep 9, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Circulating proteins and bone mineral density: A Proteome-Wide Mendelian Randomization Study.
Tianyi Wang1,2, Liu Liu1,3, Ruiying Han1,2
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu, 610041, China.
This study identifies novel genetic targets for bone mineral density (BMD) using proteome-wide Mendelian randomization, offering new avenues for osteoporosis drug development and repurposing.
Area of Science:
- Genetics and Genomics
- Pharmacology and Drug Development
- Bone Biology and Osteoporosis Research
Background:
- Current osteoporosis medications have limitations in efficacy.
- Identifying novel druggable genetic targets is crucial for developing improved osteoporosis treatments.
- Mendelian randomization (MR) offers a robust method to identify causal genetic associations, overcoming limitations of traditional observational studies.
Purpose of the Study:
- To identify novel, druggable genetic targets for bone mineral density (BMD) using a large-scale proteome-wide Mendelian randomization (pQTL) approach.
- To validate identified targets through expression quantitative trait loci (eQTL) analysis and functional experiments.
- To explore potential for drug repurposing and development for osteoporosis.
Main Methods:
- Employed two-sample Mendelian randomization (MR) utilizing protein quantitative trait loci (pQTL) and expression quantitative trait loci (eQTL) data.
- Meta-analyzed pQTL evidence across large datasets (deCODE, UKB-PPP) for six bone mineral density (BMD) sites.
- Conducted MR sensitivity tests, assessed druggability, and performed functional analyses including transcriptomics and OVX experiments.
Main Results:
- Identified 16 prioritized targets from 5,928 pQTLs, with four novel key druggable targets for BMD: LYN, CHAD, TNFRSF19, and TGFBI.
- Validated previously suggested targets RSPO3 and SMOC2.
- Functional analysis revealed elevated TNFRSF19 and TGFBI expression negatively correlated with BMD.
Conclusions:
- This large-scale Proteome-Wide MR study successfully identified novel genetic targets for BMD at both transcriptional and translational levels.
- The findings provide new therapeutic insights and present promising prospects for osteoporosis drug repurposing and development.
- The identified targets (CHAD, LYN, TGFBI, TNFRSF19) represent significant advancements in understanding BMD regulation.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Skeleton and Calcium Homeostasis
The Bone Matrix

